Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared on X:
“Looking forward to Tom Powles presenting the VOLGA trial at ESMO Presidential Session on Sat, Oct 24!
Congrats Tom, on yet another practice changing work in urothelial cancer!
This trial will address several important questions about optimal dosing of EV-IO and need for adjuvant EV.”
You can also read:
Positive VOLGA Phase III Results for Imfinzi Plus Neoadjuvant EV in MIBC
